Inogen (INGN) Competitors

Inogen (NASDAQ:INGN) and AxoGen (NASDAQ:AXGN) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their media sentiment, valuation, dividends, profitability, risk, earnings, analyst recommendations, institutional ownership and community ranking.

Which has stronger valuation and earnings, INGN or AXGN?

AxoGen has lower revenue, but higher earnings than Inogen. AxoGen is trading at a lower price-to-earnings ratio than Inogen, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Inogen	$335.71M	0.57	-$102.45M	-$1.52	-4.68
AxoGen	$187.34M	3.87	-$21.72M	-$0.22	-74.41

Do institutionals & insiders hold more shares of INGN or AXGN?

89.9% of Inogen shares are held by institutional investors. Comparatively, 80.3% of AxoGen shares are held by institutional investors. 1.5% of Inogen shares are held by insiders. Comparatively, 7.0% of AxoGen shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Do analysts rate INGN or AXGN?

Inogen currently has a consensus target price of $7.00, indicating a potential downside of 1.69%. AxoGen has a consensus target price of $22.60, indicating a potential upside of 38.06%. Given AxoGen's stronger consensus rating and higher probable upside, analysts plainly believe AxoGen is more favorable than Inogen.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Inogen	0 Sell rating(s)	2 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00
AxoGen	0 Sell rating(s)	0 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	3.00

Does the media refer more to INGN or AXGN?

In the previous week, AxoGen had 3 more articles in the media than Inogen. MarketBeat recorded 7 mentions for AxoGen and 4 mentions for Inogen. Inogen's average media sentiment score of 1.55 beat AxoGen's score of 0.88 indicating that Inogen is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Inogen	3 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive
AxoGen	5 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Is INGN or AXGN more profitable?

AxoGen has a net margin of -7.91% compared to Inogen's net margin of -15.89%. AxoGen's return on equity of -14.91% beat Inogen's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Inogen	-15.89%	-27.38%	-16.77%
AxoGen	-7.91%	-14.91%	-7.49%

Which has more volatility and risk, INGN or AXGN?

Inogen has a beta of 1.48, indicating that its share price is 48% more volatile than the S&P 500. Comparatively, AxoGen has a beta of 1, indicating that its share price has a similar volatility profile to the S&P 500.

Does the MarketBeat Community favor INGN or AXGN?

AxoGen received 68 more outperform votes than Inogen when rated by MarketBeat users. Likewise, 72.89% of users gave AxoGen an outperform vote while only 68.85% of users gave Inogen an outperform vote.

Company	Underperform	Outperform
Inogen	Outperform Votes 389 68.85%	Underperform Votes 176 31.15%
AxoGen	Outperform Votes 457 72.89%	Underperform Votes 170 27.11%

Summary

AxoGen beats Inogen on 13 of the 18 factors compared between the two stocks.